Author:
Rosenbaum S. E.,Wu S.,Newman M. A.,West D. P.,Kuzel T.,Lacouture M. E.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Azad A, Annunziata C, Barrett T, Chen C, Steinberg S, Kwitkowski VE, McNally D, Kotz H, Minasian L, Kohn EC (2007) Dual targeting of vascular endothelial growth factor (VEGF) with sorafenib and bevacizumab: clinical and translational results. J Clin Oncol, ASCO Annual Meeting Proceedings Part I 25(18S):3542
2. Bang Y, Kang Y, Kang W, Boku N, Chung H, Lanzalone S, Lechuga MJ, Sherman L, Chao R, Sobrero A (2007) Sunitinib as second-line treatment for advanced gastric cancer: preliminary results from a phase II study. J Clin Oncol 25:4603
3. Bello CL, Sherman L, Zhou J, Verkh L, Smeraglia J, Mount J, Klamerus KJ (2006) Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects. Anticancer Drugs 17:353–358
4. Bhojani N, Jeldres C, Patard JJ, Perrotte P, Suardi N, Hutterer G, Patenaude F, Oudard S, Karakiewicz PI, (2007) Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma. Eur Urol DOI 10.1016/j.euroro.2007.11.037 , Nov 26 [Epub ahead of print]
5. Botchkareva NV, Khlgatian M, Longley BJ, Botchkarev VA, Gilchrest BA (2001) SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. Faseb J 15:645–658
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献